Possible Recommendation against 臨薬協、AMDD、EBC
For developers: integration details
You do not need this for normal browsing. Use it when integrating this enforcement record into an internal tool or AI workflow.
/api/v1/enforcements?company=%E8%87%A8%E8%96%AC%E5%8D%94%E3%80%81AMDD%E3%80%81EBC&limit=10Action summary
- Company
- 臨薬協、AMDD、EBCJapanese originalOriginal: 臨薬協、AMDD、EBC
- Entity match
- Possible entity match60/100Machine extractedCompany name extracted from the Japanese public disclosure
- Governing law
- Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices薬機法
- Action type
- Recommendation勧告
- Action date
- Unknown
- Issuing authority
- Ministry of Health, Labour and Welfare厚生労働省
Violation
Show original Japanese text
体外診のクラス分類の見直し、根拠資料の考え方、添付文書の電子化、規制調和のための協議、管理者資格要件の見直し、責任者の運用改善、QMS調査制度の国際整合化など。
Compliance context
MediumA regulator issued a recommendation or formal request for corrective action.
Health product law covering pharmaceuticals, medical devices, cosmetics, quasi-drugs, labeling, and advertising.
Review the facts and follow-up status. This is usually less severe than a suspension or revocation, but still a public enforcement signal.
This context is an operational aid for review workflows, not a credit opinion or legal conclusion.
Evidence pack
- Extracted at
- 2026-05-04T12:02:36.94+00:00
- Evidence checked
- 2026-05-04T12:02:36.94+00:00
- Archive captured
- 2026-05-04T12:02:37.429+00:00
Show audit JSON
{
"record": {
"id": "27c18343-7347-45ae-bfe8-cef50f29d1bf",
"url": "https://regbase.jp/en/enforcement/yakkiho-lin-yao-xieamddebc-unknown",
"company_name_original": "臨薬協、AMDD、EBC",
"company_name_registry": "臨薬協、AMDD、EBC",
"corporate_number": null,
"law": {
"ja": "薬機法",
"en": "Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices"
},
"action_type": {
"ja": "勧告",
"en": "Recommendation"
},
"authority": {
"ja": "厚生労働省",
"en": "Ministry of Health, Labour and Welfare"
}
},
"entity_match": {
"status": "possible",
"confidence": 60,
"method": "extracted_japanese_name",
"method_label": "Company name extracted from the Japanese public disclosure",
"notes": null
},
"review": {
"status": "unreviewed",
"label": "Machine extracted"
},
"compliance_context": {
"severity": "Medium",
"actionMeaning": "A regulator issued a recommendation or formal request for corrective action.",
"practicalNote": "Review the facts and follow-up status. This is usually less severe than a suspension or revocation, but still a public enforcement signal.",
"lawContext": "Health product law covering pharmaceuticals, medical devices, cosmetics, quasi-drugs, labeling, and advertising."
},
"evidence": {
"recordUrl": "https://regbase.jp/en/enforcement/yakkiho-lin-yao-xieamddebc-unknown",
"officialSourceUrl": "https://www.mhlw.go.jp/stf/newpage_65484.html",
"archiveUrl": "https://kiroku.today/view/8869646b79r5gtgk",
"archiveCapturedAt": "2026-05-04T12:02:37.429+00:00",
"extractedAt": "2026-05-04T12:02:36.94+00:00",
"translatedAt": null,
"evidenceCheckedAt": "2026-05-04T12:02:36.94+00:00",
"generatedAt": "2026-06-19T09:10:22.528Z"
},
"limitations": [
"RegBase aggregates public Japanese government disclosures and does not provide a credit opinion.",
"English summaries are provided for reference. The original Japanese source is authoritative.",
"Possible or unresolved entity matches should be manually verified before use in a decision."
]
}The original Japanese disclosure is the authoritative record. Use possible or unresolved matches only as leads for manual review.
Language
日本語版を見る (Japanese)Company info
- English name
- 臨薬協、AMDD、EBC Japanese original
- Japanese name
- 臨薬協、AMDD、EBC
About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.